HH-101 / Huahui Health - LARVOL DELTA

A Reproducible Benchmark-Validity Audit and Calibration Study for Cross-Home Fault Diagnosis in Smart-Home Sensor Systems. (PubMed, Sensors (Basel)) - "Using the public Center for Advanced Studies in Adaptive Systems (CASAS) smart-home datasets (homes hh101-hh110) and real household power data (HomeC, UMass Smart*), we show that much of the high cross-home accuracy reported on these benchmarks is an artifact of features that re-encode the labelling rules rather than evidence of transfer: when those features are removed, the macro-averaged F1 score (macro-F1) collapses toward the level obtained with randomly permuted labels...The results are intended for researchers who build or benchmark sensor-based fault-diagnosis models, for dataset curators, and for practitioners who need calibrated rather than merely accurate outputs. All code, the proxy-label rules, and the leakage audit are released."

Journal

A Phase 1 Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HH-101 in Patients With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=12 | Completed | Sponsor: Huahui Health

Monotherapy • New P1 trial • Oncology • Solid Tumor